Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ellen Fraint

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Bone Marrow Transplantation|September 4, 2023
No impact of CD34<sup>+</sup> cell dose on outcome among children undergoing autologous hematopoietic stem cell transplant for high-risk neuroblastomaTristan E Knight, Kwang Woo Ahn, Kyle M Hebert, et al.
Leukemia|November 6, 2022
Outcomes of first therapy after CD19-CAR-T treatment failure in large B-cell lymphomaAna Alarcon Tomas, Joshua A Fein, Shalev Fried, et al.
Frontiers in Immunology|November 15, 2023
Mediport use as an acceptable standard for CAR T cell infusionMaya Eylon, Snehit Prabhu, Samuel John, et al.
Transplantation and Cellular Therapy|November 14, 2025
Acute Toxicities and Early Outcomes of Tandem Autologous Stem Cell Transplantation in Pediatric High-Risk Neuroblastoma: A Multicenter StudyZahra Hudda, Aaron Webster, Eric Anderson, et al.
Transplantation and Cellular Therapy|July 26, 2021
Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular TherapyMohamed A Kharfan-Dabaja, Ambuj Kumar, Ernesto Ayala, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Bone Marrow Transplantation|September 4, 2023
No impact of CD34<sup>+</sup> cell dose on outcome among children undergoing autologous hematopoietic stem cell transplant for high-risk neuroblastomaTristan E Knight, Kwang Woo Ahn, Kyle M Hebert, et al.
Leukemia|November 6, 2022
Outcomes of first therapy after CD19-CAR-T treatment failure in large B-cell lymphomaAna Alarcon Tomas, Joshua A Fein, Shalev Fried, et al.
Frontiers in Immunology|November 15, 2023
Mediport use as an acceptable standard for CAR T cell infusionMaya Eylon, Snehit Prabhu, Samuel John, et al.
Transplantation and Cellular Therapy|November 14, 2025
Acute Toxicities and Early Outcomes of Tandem Autologous Stem Cell Transplantation in Pediatric High-Risk Neuroblastoma: A Multicenter StudyZahra Hudda, Aaron Webster, Eric Anderson, et al.
Transplantation and Cellular Therapy|July 26, 2021
Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular TherapyMohamed A Kharfan-Dabaja, Ambuj Kumar, Ernesto Ayala, et al.
Pageof 3